The investment objective of the scheme is to provide returns that correspond to the total returns of the securities as represented by the underlying index, subject to tracking error.
Expert-managed portfolios tailored to your financial goals and risk appetite.
| Index Funds | 1M | 3M | 6M | 9M | 1Y | 2Y | 3Y | 4Y | 5Y | 10Y | ALL |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Fund returns | -1.61% | -5.2% | -1.65% | -7.16% | -3.83% | N/A | N/A | N/A | N/A | N/A | 6.05% |
| Category returns | -3.49% | -4.55% | -2.01% | -3.44% | -4% | -2.79% | 10.35% | 12.84% | 9.89% | 11.22% | N/A |
| Absolute returns | -1.61% | -5.2% | -1.65% | -7.16% | -3.83% | N/A | N/A | N/A | N/A | N/A | 10.5% |
| Rank within category | 31/216 | 92/207 | 59/199 | 128/193 | 73/184 | N/A | N/A | N/A | N/A | N/A | N/A |
| Index Funds | 2025 | 2026 |
|---|---|---|
| Yearly returns | N/A | -6.71% |
| Q1 returns | N/A | -15.74% |
| Q2 returns | 11.44% | 14.85% |
| Q3 returns | -4.53% | -5.05% |
| Q4 returns | 8.87% | 1.53% |
0.25% on or before 15D, Nil after 15D
| Alpha | -0.0653268 |
| Beta | 1.0005 |
| Sharpe Ratio | 0.0416806 |
| Sortino Ratio | 0.0668681 |
| R-Squared | 0.9945 |
| Tracking Error | 0.1056 |
| Downside Risk | 18.8606 |
| Std. Deviation (Annualised) | 15.6527 |
| Index Funds | 1M | 3M | 6M | 9M | 1Y | 3Y | 5Y | 10Y | ALL | Fund Size (Cr) | Exp. Ratio | Sharpe | Risk |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ICICI Prudential NASDAQ 100 Index Fund - Growth | -1.52% | 1.37% | 12.73% | 20.33% | 27.46% | 30.85% | 18.72% | N/A | 18.87% | 3,738.17 | 1.06 | 0.39 | Very High |
| Motilal Oswal S&P 500 Index Fund - Regular Plan - Growth | -0.5% | 1.6% | 10.19% | 15.5% | 24.15% | 26.62% | 16.54% | N/A | 19.94% | 4,584.30 | 1.04 | 0.44 | Very High |
| ICICI Prudential Nifty Pharma Index Fund - Regular Plan - Growth | -4.18% | -0.29% | 13.6% | 15.38% | 14.48% | 18.13% | N/A | N/A | 18.71% | 163.10 | 1.18 | 0.29 | Very High |
| UTI Nifty 500 Value 50 Index Fund - Regular Plan - Growth | -4.93% | -6.29% | -9.73% | -4.85% | 2.97% | 18.1% | N/A | N/A | 23.08% | 838.01 | 1.21 | 0.22 | Very High |
| Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund - Regular Plan - Growth | -4.3% | -1.59% | 11.56% | 11.09% | 13.2% | 17.83% | 12.7% | N/A | 14.93% | 191.85 | 1.10 | 0.32 | Very High |
| Motilal Oswal BSE Enhanced Value Index Fund - Regular Plan - Growth | -3.42% | -6.2% | -9.67% | -9.99% | -0.86% | 17.49% | N/A | N/A | 24.9% | 2,131.66 | 1.12 | 0.19 | Very High |
| Aditya Birla Sun Life Nifty Smallcap 50 Index Fund - Regular Plan - Growth | -4.83% | -1.02% | 10.76% | 12.27% | 8.48% | 15.62% | 10.2% | N/A | 15.72% | 364.19 | 1.11 | 0.18 | Very High |
| Kotak Nifty Smallcap 50 Index Fund - Regular Plan - Growth | -5.01% | -1.19% | 10.63% | 11.86% | 8.08% | 15.42% | N/A | N/A | 24.48% | 259.53 | 0.92 | 0.18 | Very High |
| ICICI Prudential Nifty Auto Index Fund - Regular Plan - Growth | -5.75% | -5.5% | -2.85% | -7.06% | -5.92% | 15.29% | N/A | N/A | 19.15% | 234.49 | 0.95 | 0.18 | Very High |
| SBI Nifty Bank Index Fund - Regular Plan - Growth Current | -1.61% | -5.2% | -1.65% | -7.16% | -3.83% | N/A | N/A | N/A | 6.05% | 199.01 | 0.76 | 0.04 | Very High |
| Name | Sector | Instrument | Assets % |
|---|---|---|---|
| HDFC Bank Ltd. | Banks | Domestic Equities | 18.62% |
| ICICI Bank Ltd. | Banks | Domestic Equities | 14.18% |
| Kotak Mahindra Bank Ltd. | Banks | Domestic Equities | 10.20% |
| Axis Bank Ltd. | Banks | Domestic Equities | 10.06% |
| State Bank Of India | Banks | Domestic Equities | 9.93% |
| The Federal Bank Ltd. | Banks | Domestic Equities | 6.56% |
| IndusInd Bank Ltd. | Banks | Domestic Equities | 4.97% |
| AU Small Finance Bank Ltd. | Banks | Domestic Equities | 4.85% |
| IDFC First Bank Ltd. | Banks | Domestic Equities | 4.54% |
| Bank Of Baroda | Banks | Domestic Equities | 3.59% |
| Canara Bank | Banks | Domestic Equities | 3.37% |
| Punjab National Bank | Banks | Domestic Equities | 3.27% |
| Yes Bank Ltd. | Banks | Domestic Equities | 3.01% |
| Union Bank Of India | Banks | Domestic Equities | 2.86% |
| TREPS | Cash & Cash Equivalents and Net Assets | 0.48% | |
| Net Receivable / Payable | Cash & Cash Equivalents and Net Assets | -0.49% | |
| Total | 100.00% | ||
Mr. Viral Chhadva (Equity Dealer) joined SBIFML in December 2020. He has over 17 years of experience in financial services sector. Prior to joining SBIFML, he was previously associated with IIFL Securities Limited (June 2008 till December 2020) and ICICI Securities Limited (June 2006 till June 2008) wherein he primarily handled execution of trades into Direct Market Access, Exchange Traded Funds and Derivatives.
Get personalized portfolio management services designed to grow and protect your wealth.
ChatGPT
Claude
Perplexity
